From the 1st to 2nd October 2025 in Barcelona, this summit will unite 50+ industry experts to tackle critical challenges in obesity drug development, from novel targets and clinical trial design to manufacturing breakthroughs and payer strategies. Whether you’re exploring GLP-1 combinations, RNA-based platforms, or real-world evidence, this is your chance to shape the future of a $100 billion market.